Your gateway to world-class research journals


Invited Article

Attempts for Remedies for Novel Coronavirus SARS-CoV-2 Infection: Drugs, Antibodies, Vaccine

Dr Alok Bondyopadhyay




In the year of 2019, a novel corona virus designated as SARS-CoV-2 was discovered in samples of broncho-alveolar lavage fluid from a patient of Wuhan, China, and the disease caused by this virus is known as Covid-19. The virus is highly contagious and transmits through person to person contact and deadly in nature. A few works were done on the biochemical and immunological characterisations. Due to its deadly nature scientists are trying to prevent the infection from various aspects eg, drugs, antibodies, and vaccine. Within drugs group antiviral agent remdesivir yielded good results in phase I clinical trial and a few others are in process. Scientists are pursuing with anti-inflammatory agents and dexamethasone which showed promising results. Various antibodies including convalescent serum and monoclonal antibodies are also tried in clinical trials and results are in process. Since Covid-19 originated from SARS-CoV-2 infection, so scientists believe vaccine will be a better medicine. Several companies and universities are trying to develop vaccine. Preliminary results of some of these vaccines are promising. Further work is in progress. Overall, scientists are working in several areas for the prevention of Covid-19 disease.


SARS-CoV-2, antibodies, vaccine

Journal: Medical Glory Vol 4, Issue No 3, July-September, 2020


View Article 

You need to login to access the article.